Vect-Horus is a startup based in France, most recent round Series-c-plus, 1 tracked investor.
Based in France, Vect-Horus is a startup founded in 2017. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Vect-Horus is a biotechnology company that develops molecular vectors using its proprietary VECTrans® technology to facilitate the targeted delivery of therapeutic and imaging agents to organs, including the brain and tumors. They operate with a mixed business model, developing an internal pipeline of drug candidates and partnering with pharmaceutical companies for research collaborations and licensing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.